| 14:10 - 14:40 | |
Makoto Yokota |
|
| Deputy Director of C-PIER, Kyoto University. |
|
| Curriculum Vitae: March 1982 Graduated from Faculty of Engineering, Department of Synthetic Chemistry, Tokyo University March 1984 Graduated from Graduate School of Engineering, Department of Synthetic Chemistry, Tokyo University April, 1984 Join the Ministry of International Trade and Industry (Current METI) May, 1999 Director, Abandoned Chemical Weapon Office, Cabinet Office May, 2001 Director-General, JETRO Los Angeles June, 2004 Director, Standardization Planning Office, METI July, 2006 Director, Recycling Promotion Division, METI July, 2007 Director-General, Economic Policy Department, Kanto Bureau, METI July, 2008 Counsellor, Secretariat of Strategic Headquarters for Space Policy, Cabinet Secretariat August, 2010 General Manager, Corporate Planning Department, ZEON Corporation July, 2012 Vice-Director, Project Professor, Center for the Promotion of Interdisciplinary Education and Research, Kyoto University |
|
Current GOJ approach for commercialization and industrialization of regenerative medicine Dr. Yamanaka’s Nobel award is promoting Japanese government’s active approach for commercialization and industrialization of regenerative medicine. In this April, the Regenerative Medicine Promotion Law was enacted. And the two other related bills were submitted to the Diet in this May (unfortunately, those bills were not enacted in the last term). I would like to show the background and current situation of the Japanese government approach to regenerative medicine. |
| 14:40 - 15:10 | |
Sachiko Kamiyama |
|
| Principal Investigator, The Kaiteki Institute Co. (Mitsubishi Chemical Holdings, Co.) Education: Department of Agricultural Chemistry, Faculty of Agriculture, Tokyo University of Agriculture, Master of Science, Agricultural chemistry Work Experience:
|
|
The KAITEKI Institute (TKI) was established by Mitsubishi Chemical Holdings Corporation in order to study ways to realize KAITEKI in society. Humanity is now at a critical point in history, facing serious problems such as environmental change, depletion of energy and resources, water and food shortage, and aging society in developed countries. What we refer to by ‘KAITEKI’ is a state in which all of these problems are solved; a state of true sustainability that represents comfort not only for people, but also for society and the planet as a whole. TKI works towards the realization of KAITEKI, taking a long-term perspective that looks 20 to 50 years into the future. The issue of aging society, which is one of the main research themes of TKI, will be discussed in this session. Increasing the population of aging people is sometimes thought as a negative social issue because of increasing the cost of social welfare. But TKI realize that aging society is a future figure and it is important to create it as healthy as possible for both of old and young. We have still many things unknown about changes in their health and awareness accompanying aging. In order to shed light on the reality of this situation, we worked with Professor Hiroko Akiyama of The University of Tokyo who is an expert on gerontology, analyzed the panel data which was collected in US and Japan by her. I am going to report some of new findings regarding health condition of elderly people, especially changes in their level of physical independence in their daily life. |
| 15:10 - 15:40 | |
Jun Miyake |
|
| Professor, Graduate School of Engineering Science, Osaka University. | |
Education: BS. School of Science, Osaka Univ.(1975), Ph.D. (1980). Research Carrier: 1980-2009 AIST. 2007-2009 Director, Institute of Cell Engineering. 2009 Professor, Osaka Univ. 2001-2010 Univ. Tokyo School of Engineering, Invited Professor, 2005-2010 Operating Agent, IEA-HIA Annex21. Achievements and Main Awards: Over 450 publications and 100 patents. Prize of Minister of Science and Technology Agency, Prize of Minister of International Trade and Industry, Akira Mitsui-Memorial Award from International Association of Hydrogen Energy. Personal Interests: Bicycle and Modern arts. |
| 15:40 - 16:10 | |
Colin J.H. Brenan |
|
| Ph.D. CTO SVP, Business Development HiFiBiO SAS |
|
A Tale of Two Technologies: Reflections on the Translation of University-developed Technologies into Commercially Successful Life Science Products It looks easy from the outside – an entrepreneur with a hot technology and venture capital funding becomes a billionaire in his 20s. The reality however is quite different. A recent Harvard Business School study reported 3 out of 4 venture-backed start-ups fail. Why? Translation of university-developed technologies into marketable products and services is fraught with seemingly insurmountable hurdles, pitfalls, missteps and challenges. In this talk, I identify and document my experiences in transforming bench-top technologies into commercially viable products and services. To illustrate the process from concept to exit, I present as a case study BioTrove Inc. – a start-up company I co-founded with colleagues from MIT to commercialize the nanofluidic and high throughput mass spectrometry technologies we invented. Through BioTrove, we created the Open ArrayTM and RapidFireTM businesses that were acquired by Life Technologies (NASDAQ:LIFE) and Agilent Inc. (NYSE:A), respectively. I will use these examples to illustrate the general principles behind winning start-ups and summarize the lessons I’ve learned that guide me in my current life science start-up, HiFiBiO SAS. |
| 18:00 *The Participation Fee for a dinner session is 10,000 yen. | |
Dinner Session |
|
| at SAKURA KITASHINCHI HONTEN |
|
| Participation fee: JPY10,000 Capacity: 30 Meeting Time/Place: 17:30@the Main Lobby of ANA Crown Plaza Hotel http://www.ihg.com/crowneplaza/hotels/us/en/osaka,-osaka/osaja/hoteldetail/directions It takes 10 minutes by walk from Osaka International Convention Center to the hotel. |
|